Literature DB >> 10640677

Differential expression of neural cell adhesion molecule isoforms in normal and glaucomatous human optic nerve heads.

C S Ricard1, J D Pena, M R Hernandez.   

Abstract

Type 1B astrocytes of the human optic nerve head (ONH) constitutively express neural cell adhesion molecule (NCAM) in vivo and in vitro. Increased synthesis of NCAM has been detected in reactive astrocytes in the glaucomatous ONH of human donor eyes. Several NCAM isoforms are generated through alternate RNA splicing in tissue- and disease-specific patterns. In this study, we analyzed expression of NCAM isoforms in ONH of normal donors at different ages and in glaucoma. Total RNA was extracted from ONH of fetal, normal adult and glaucomatous eyes, and cultured human ONH astrocytes, fetal brain astrocytes and an astrocytoma cell line, for reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. To distinguish between NCAM 180 and 140 isoforms, exon-specific primer sets covering exons 13-19 were used. Isoform-specific riboprobes were used for in situ hybridization (ISH) in glaucomatous and in age-matched ONH. By RT-PCR, NCAM 140 was the predominant isoform in adult ONH as well as in all cultured cells. NCAM 180 mRNA was strongly expressed in glaucoma, whereas in normal adult tissues it was not detectable. ISH confirmed expression of NCAM in normal adult ONH and localized NCAM 140 mRNA to astrocytes. ISH demonstrated expression of NCAM 180 mRNA in reactive astrocytes in glaucomatous ONH. Our results demonstrate that the NCAM 180 isoform is induced in glaucoma. NCAM 180 may play a role in astrocyte interaction with extracellular matrix (ECM), vessels, axons and other astrocytes and, through its expanded cytoplasmic domain, serve as a signaling molecule for reactive astrocytes during remodeling of the ONH in glaucoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10640677     DOI: 10.1016/s0169-328x(99)00264-8

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  7 in total

1.  Isolation and characterization of human optic nerve head astrocytes and lamina cribrosa cells.

Authors:  Navita N Lopez; Abbot F Clark; Tara Tovar-Vidales
Journal:  Exp Eye Res       Date:  2020-06-06       Impact factor: 3.467

Review 2.  Major review: Molecular genetics of primary open-angle glaucoma.

Authors:  Yutao Liu; R Rand Allingham
Journal:  Exp Eye Res       Date:  2017-05-10       Impact factor: 3.467

3.  Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma.

Authors:  Gülgün Tezel; Ivey L Thornton; Melissa G Tong; Cheng Luo; Xiangjun Yang; Jian Cai; David W Powell; Joern B Soltau; Jeffrey M Liebmann; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

4.  Alterations in the morphology of lamina cribrosa pores in glaucomatous eyes.

Authors:  G Tezel; K Trinkaus; M B Wax
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

5.  Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors.

Authors:  Laura Todaro; Silvia Christiansen; Mirta Varela; Paola Campodónico; M Guadalupe Pallotta; José Lastiri; Eugenia Sacerdote de Lustig; Elisa Bal de Kier Joffé; Lydia Puricelli
Journal:  J Neurooncol       Date:  2007-01-10       Impact factor: 4.506

6.  Whole-exome sequencing identifies multiple pathogenic variants in a large South Indian family with primary open-angle glaucoma.

Authors:  Mohd Hussain Shah; Manojkumar Kumaran; Prakash Chermakani; Mohideen Abdul Kader; R Ramakrishnan; Subbiah R Krishnadas; Bharanidharan Devarajan; Periasamy Sundaresan
Journal:  Indian J Ophthalmol       Date:  2021-09       Impact factor: 1.848

7.  Differential global and extra-cellular matrix focused gene expression patterns between normal and glaucomatous human lamina cribrosa cells.

Authors:  Ruaidhrí P Kirwan; Robert J Wordinger; Abbot F Clark; Colm J O'Brien
Journal:  Mol Vis       Date:  2009-01-15       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.